
A Vaccine Won’t Be the End
About this episode
As of Sept. 24, there are 42 vaccines in clinical trials on humans. At least 92 others are being developed but have not yet gone to trial. For months, the world has tracked the progression of these vaccines closely, with the expectation that once one arrives on the market, we can finally start to go back to normal. But, is that true? Does the world really look much different with an effective vaccine?
Guest: Dr. Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia.
Host
Celeste Headlee
Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time What Next: TBD | Tech, power, and the future publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What Next: TBD | Tech, power, and the future

Meta Settled. Is it a "Reckoning?"
What Next: TBD | Tech, power, and the future

A.I. Enshittifies Everything (Still)
What Next: TBD | Tech, power, and the future

Can the Midterms Withstand Prediction Markets?
What Next: TBD | Tech, power, and the future

Are Flock Cameras Watching You?
What Next: TBD | Tech, power, and the future